This inventor holds 8 USPTO granted patents and 4 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignees: Daiichi Pharmaceutical Co., Ltd., Daiichi Sankyo Company, Limited. Active years: 1997-2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Edogawa-ku, JP (2007)
- Shinagawa-ku, JP (2015)
- Tokyo, JP (1997 - 2017)
Company Filing History:

Years Active: 1997-2017
Title: Hiroaki Nakagami: Innovator in Pharmaceutical Composition
Introduction
Hiroaki Nakagami is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceuticals, holding a total of 8 patents. His work focuses on developing pharmaceutical compositions that exhibit satisfactory dissolution properties across a wide pH range.
Latest Patents
Among his latest patents, Nakagami has developed a pharmaceutical composition characterized by the inclusion of N-(5-chloropyridin-2-yl)-N-((1S,2R,4S)-4-[(dimethylamino)carbonyl]-2-{[(5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridin-2-yl)carbonyl]amino}cyclohexyl)ethanediamide. This composition also contains one or more species selected from the group consisting of a sugar alcohol and a water-swelling additive. This innovative approach aims to enhance the effectiveness of pharmaceutical preparations.
Career Highlights
Hiroaki Nakagami has worked with notable companies in the pharmaceutical industry, including Daiichi Pharmaceutical Co., Ltd. and Daiichi Sankyo Company, Limited. His experience in these organizations has allowed him to refine his expertise in pharmaceutical development and innovation.
Collaborations
Throughout his career, Nakagami has collaborated with esteemed colleagues such as Masazumi Kojima and Shinji Sagasaki. These partnerships have contributed to the advancement of his research and the successful development of his patented compositions.
Conclusion
Hiroaki Nakagami's contributions to pharmaceutical innovation are noteworthy, particularly in the area of dissolution properties of drug formulations. His work continues to impact the pharmaceutical industry positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile